California Public Employees Retirement System’s Allogene Therapeutics ALLO Stock Holding History

California Public Employees Retirement System’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-106,488	Closed	-$3.76M	–	1586
2021 Q1	$3.76M	Sell	106,488 -10,158	-9%	-$343K	﹤0.01%	1604
2020 Q4	$2.94M	Buy	116,646 +4,746	+4%	+$155K	﹤0.01%	1751
2020 Q3	$4.22M	Buy	111,900 +13,112	+13%	+$494K	﹤0.01%	1348
2020 Q2	$4.23M	Buy	98,788 +2,188	+2%	+$79.1K	﹤0.01%	1291
2020 Q1	$1.88M	Sell	96,600 -5,300	-5%	-$126K	﹤0.01%	1644
2019 Q4	$2.65M	Buy	101,900 +3,628	+4%	+$99.9K	﹤0.01%	1861
2019 Q3	$2.68M	Buy	98,272 +78,972	+409%	+$2.25M	﹤0.01%	1705
2019 Q2	$518K	Buy	+19,300	New	+$538K	﹤0.01%	2512

Other funds holding ALLO

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

California Public Employees Retirement System's ALLO Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Allogene Therapeutics (ALLO) in Q2 2021, closing a stake of 106,488 shares — an estimated $3.76M sold.

California Public Employees Retirement System first reported a position in ALLO in Q2 2019 and held it in 8 quarters. The position peaked at $4.23M in Q2 2020. 182 funds tracked by Wall St. Rank hold ALLO as of Q2 2021.

California Public Employees Retirement System reported no remaining Allogene Therapeutics position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 106,488 Allogene Therapeutics shares in Q2 2021, an estimated $3.76M.
California Public Employees Retirement System first reported a position in Allogene Therapeutics in Q2 2019 and held it in 8 quarters.
California Public Employees Retirement System's Allogene Therapeutics position peaked at $4.23M in Q2 2020.
182 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.